Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

NorthSea Therapeutics

Request full access

Pan-European biotech company with the aim to develop novel and innovative therapeutic strategies for NASH and other metabolic, inflammatory and fibrotic diseases

Amsterdam, NetherlandsFounded 2017Biotech & Life Sciences

About NorthSea Therapeutics

NorthSea Therapeutics is a clinical-stage biotech company focused on developing innovative therapies for Non-Alcoholic SteatoHepatitis (NASH) and other metabolic, inflammatory, and fibrotic diseases. The company operates primarily in the US, Western Europe, and Japan, targeting a market with an estimated 15-30 million patients affected by NASH. NorthSea's lead program, icosabutate, is a first-in-class Structurally Engineered Fatty Acid (SEFA) currently in late-stage clinical development. The company's business model revolves around the research, development, and commercialization of these novel therapeutics. Revenue is generated through partnerships, licensing agreements, and eventual product sales upon regulatory approval. NorthSea Therapeutics aims to address the unmet medical needs in the NASH treatment landscape, offering a promising alternative to the limited options currently available.

Source: Dealroom company data

At a glance

Status
Operational
Employees
22
Open positions
None listed
Dealroom signal
71.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Digital Therapeutics, Biotech and Pharma, Hard Tech, Woman Founder, DT and LS, science-based
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Dec 2021 $80M $320M BioGeneration Ventures · venBio Partners · Novo Seeds · New Science Ventures ↗
SERIES BOther financing Jan 2020 $40M $158M Forbion Capital Partners · Novo Seeds · venBio Partners · BioGeneration Ventures —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

NorthSea Therapeutics website traffic

Latest recorded traffic for NorthSea Therapeutics is 590 monthly website visits, down 19.2% over the last three months. NorthSea Therapeutics's team grew 0% over the past year.

Latest monthly visits590 3-month web change-19.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

NorthSea Therapeutics in the Amsterdam ecosystem

Live from Dealroom

The NorthSea Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Forbion Capital Partners
  • BioGeneration Ventures
  • New Science Ventures
  • Novo Holdings
  • venBio Partners
  • Novo Seeds
  • Sofinnova Investments

Series B and later2 investors entered at this stage

  • Ysios Capital
  • Hercules Capital
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇺🇸 United States43.8%
🇳🇴 Norway25%
🇳🇱 Netherlands18.8%
🇪🇸 Spain6.3%
🇱🇹 Lithuania6.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about NorthSea Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See NorthSea Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.